Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 29, 2014 02:07 ET | Source: MdxHealth (TM)

MDxHealth to Present Results from Epigenetic Prostate Test to Identify Aggressive Prostate Cancer at the ASCO Genitourinary Cancers Symposium 2014

IRVINE, Calif. and HERSTAL, Belgium, Jan. 29, 2014 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to...
October 16, 2013 02:22 ET | Source: MdxHealth (TM)

MDxHealth's MGMT Test Included in NCCN Guidelines and Awarded Tier 1 Reimbursement Code by AMA

IRVINE, Calif. and HERSTAL, Belgium, Oct. 16, 2013 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext:MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to...
October 07, 2013 02:22 ET | Source: MdxHealth (TM)

MDxHealth's ConfirmMDx(R) Meets All Primary Endpoints in Blinded U.S. Clinical Validation Study

IRVINE, Calif. and HERSTAL, Belgium, Oct. 7, 2013 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext:MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to...
October 01, 2013 02:27 ET | Source: MdxHealth (TM)

MDxHealth Insurance Agreements Expand Access to ConfirmMDx(R) for Prostate Cancer Test

IRVINE, Calif. and HERSTAL, Belgium, Oct. 1, 2013 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext:MDXH), a leading molecular diagnostics company that develops and commercializes epigenetic tests to...